Consumers (Biologics)

Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins.
- Report a Problem to the Center for Biologics Evaluation & Research
- Impact of Severe Weather Conditions on Biological Products
- Recalls (Biologics)
- CBER-Regulated Products: Shortages and Discontinuations
- Blood Safety & Availability
- Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model
- Tissue Safety & Availability
- Vaccine Safety & Availability
Follow CBER
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Center for Biologics Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave WO71-3103
Silver Spring, MD 20993-0002
(800) 835-4709
(240) 402-8010
For Updates on Twitter, follow @fdacber